Goldman Sachs Group Inc Amgen Inc Call Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $117 Million - $127 Million	377,700 Added 1034.79%	414,200 $133 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $5.99 Million - $7.28 Million	-22,800 Reduced 38.45%	36,500 $11.4 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $4.62 Million - $5.58 Million	-17,200 Reduced 22.48%	59,300 $16.9 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $13.1 Million - $14.8 Million	51,200 Added 202.37%	76,500 $22 Million
Q3 2023 May 14, 2024	SELL	$218.65 - $271.46 $11.2 Million - $13.9 Million	-51,200 Reduced 66.93%	25,300 $6.8 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $590,355 - $732,942	2,700 Added 11.95%	25,300 $6.8 Million
Q2 2023 May 14, 2024	SELL	$214.27 - $253.37 $2.06 Million - $2.43 Million	-9,600 Reduced 29.81%	22,600 $5.02 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2.06 Million - $2.43 Million	-9,600 Reduced 29.81%	22,600 $5.02 Million
Q1 2023 May 14, 2024	SELL	$225.79 - $275.2 $35.1 Million - $42.8 Million	-155,500 Reduced 82.84%	32,200 $7.78 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $35.1 Million - $42.8 Million	-155,500 Reduced 82.84%	32,200 $7.78 Million
Q4 2022 May 14, 2024	SELL	$229.03 - $291.01 $32.8 Million - $41.7 Million	-143,300 Reduced 43.29%	187,700 $49.3 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $32.8 Million - $41.7 Million	-143,300 Reduced 43.29%	187,700 $49.3 Million
Q3 2022 May 14, 2024	BUY	$224.46 - $253.15 $50.9 Million - $57.4 Million	226,800 Added 217.66%	331,000 $74.6 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $50.9 Million - $57.4 Million	226,800 Added 217.66%	331,000 $74.6 Million
Q2 2022 May 14, 2024	BUY	$230.71 - $256.74 $6.39 Million - $7.11 Million	27,700 Added 36.21%	104,200 $25.4 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $7.01 Million - $7.8 Million	30,400 Added 41.19%	104,200 $25.4 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $6.18 Million - $6.84 Million	28,200 Added 61.84%	73,800 $17.8 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $5.81 Million - $6.65 Million	29,200 Added 178.05%	45,600 $10.3 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $3.48 Million - $4.08 Million	16,400 New	16,400 $3.49 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account